Latisse Ophthalmic Solution
Bimatoprost solution for inadequate eyelashes. It extends the growth phase of each lash, so they become longer and denser.
- Category
- Eye Care
- Active ingredient
- Bimatoprost
- Route
- Ocular use
- Form
- Ophthalmic Solution
- Strengths
- 0.03%
Supply requirements for Latisse Ophthalmic Solution depend on the medicine and destination. The fulfilment partner must confirm them before accepting an order.
Latisse Ophthalmic Solution details
- Condition
- Eyelash Hypotrichosis
- Alternative names
- bimatoprost
- Therapeutic class
- Topical Ophthalmic Agent
- Pharmacological class
- Prostaglandin Analog
- Known off-label uses
- ocular hypertension
- Contraindications
- hypersensitivity to bimatoprost
- Minor side effects
- conjunctival hyperaemia; eye pruritus; dry eyes
- Moderate side effects
- eyelash growth; skin hyperpigmentation; iris pigmentation change
- Serious side effects
- macular oedema, requires immediate medical attention
- Dosage forms
- Ophthalmic Solution
- Administration route
- Ocular use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Allergan
- Onset Time
- 4–8 weeks
- Storage instructions
- Store below 25°C.
- Age restrictions
- Approved for adults.
Patient summary
Bimatoprost solution for inadequate eyelashes. It extends the growth phase of each lash, so they become longer and denser.
Mechanism of action
Stimulates the anagen (growth) phase of eyelash follicles, prolonging follicle activation to increase lash length and density.
Pregnancy and breastfeeding
Pregnancy: Minimal absorption. Use if potential benefit outweighs risk. Breastfeeding: Consult a doctor.